Ultragenyx Pharmaceutical Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2023.
  • Ultragenyx Pharmaceutical Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 72.2M shares, a 2.99% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 72.2M +2.09M +2.99% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 71.5M +1.46M +2.08% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 70.7M +863K +1.24% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 70.2M +852K +1.23% Dec 31, 2022 10-Q 2023-11-03
Q3 2022 70.1M +2.12M +3.12% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 70M +2.25M +3.31% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 69.8M +2.36M +3.5% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 69.3M +2.53M +3.78% Dec 31, 2021 10-K 2023-02-17
Q3 2021 68M +7.15M +11.8% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 67.8M +7.35M +12.2% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 67.4M +7.95M +13.4% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 66.8M +8.98M +15.5% Dec 31, 2020 10-K 2022-02-15
Q3 2020 60.8M +3.07M +5.31% Sep 30, 2020 10-Q 2020-10-27
Q2 2020 60.4M +2.75M +4.77% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 59.5M +2.18M +3.81% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 57.8M +6.98M +13.7% Dec 31, 2019 10-K 2021-02-12
Q3 2019 57.7M +7.22M +14.3% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 57.7M +7.55M +15.1% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 57.3M +7.64M +15.4% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 50.9M +6.69M +15.2% Dec 31, 2018 10-K 2020-02-14
Q3 2018 50.5M +8.04M +18.9% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 50.1M +7.69M +18.1% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 49.7M +7.39M +17.5% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 44.2M +2.93M +7.1% Dec 31, 2017 10-K 2019-02-20
Q3 2017 42.5M +2.44M +6.08% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 42.4M +3.38M +8.66% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 42.3M +3.28M +8.42% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 41.2M +2.36M +6.06% Dec 31, 2016 10-K 2018-02-21
Q3 2016 40.1M +1.23M +3.17% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 39M +2.97M +8.25% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 39M +3.38M +9.49% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 38.9M +6.95M +21.8% Dec 31, 2015 10-K 2017-02-17
Q3 2015 38.8M +6.98M +21.9% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 36.1M +6.01M +20% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 35.6M +5.56M +18.5% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 31.9M 0 0% Dec 31, 2014 10-K 2016-02-26
Q3 2014 31.8M Sep 30, 2014 10-Q 2014-11-10
Q2 2014 30.1M Jun 30, 2014 10-Q 2014-08-11
Q1 2014 30M Mar 31, 2014 10-Q 2014-05-12
Q4 2013 31.9M Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.